Polymeric biomaterials in the treatment of posterior segment diseases

Polymeric biomaterials are biological or synthetic substances which can be engineered to interact with biological systems for the diagnosis or treatment of diseases. These biomaterials have immense potential for treating eyes diseases, particularly the retina—a site of many inherited and acquired di...

Full description

Bibliographic Details
Main Authors: Ivan Seah, Charles Ong, Zengping Liu, Xinyi Su
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-08-01
Series:Frontiers in Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2022.949543/full
_version_ 1798036997241044992
author Ivan Seah
Ivan Seah
Ivan Seah
Charles Ong
Zengping Liu
Zengping Liu
Zengping Liu
Xinyi Su
Xinyi Su
Xinyi Su
Xinyi Su
author_facet Ivan Seah
Ivan Seah
Ivan Seah
Charles Ong
Zengping Liu
Zengping Liu
Zengping Liu
Xinyi Su
Xinyi Su
Xinyi Su
Xinyi Su
author_sort Ivan Seah
collection DOAJ
description Polymeric biomaterials are biological or synthetic substances which can be engineered to interact with biological systems for the diagnosis or treatment of diseases. These biomaterials have immense potential for treating eyes diseases, particularly the retina—a site of many inherited and acquired diseases. Polymeric biomaterials can be engineered to function both as an endotamponade agent and to prevent intraocular scarring in retinal detachment repair surgeries. They can also be designed as a drug delivery platform for treatment of retinal diseases. Finally, they can be used as scaffolds for cellular products and provide non-viral gene delivery solutions to the retina. This perspective article explains the role of polymeric biomaterials in the treatment of retinal conditions by highlighting recent advances being translated to clinical practice. The article will also identify potential hurdles to clinical translation as future research directions in the field.
first_indexed 2024-04-11T21:20:39Z
format Article
id doaj.art-b27861e58c6843aa88b3a66dfe231725
institution Directory Open Access Journal
issn 2296-858X
language English
last_indexed 2024-04-11T21:20:39Z
publishDate 2022-08-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Medicine
spelling doaj.art-b27861e58c6843aa88b3a66dfe2317252022-12-22T04:02:39ZengFrontiers Media S.A.Frontiers in Medicine2296-858X2022-08-01910.3389/fmed.2022.949543949543Polymeric biomaterials in the treatment of posterior segment diseasesIvan Seah0Ivan Seah1Ivan Seah2Charles Ong3Zengping Liu4Zengping Liu5Zengping Liu6Xinyi Su7Xinyi Su8Xinyi Su9Xinyi Su10Department of Ophthalmology, National University Hospital, Singapore, SingaporeDepartment of Ophthalmology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, SingaporeInstitute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A*STAR), Singapore, SingaporeSingapore National Eye Centre (SNEC), Singapore, SingaporeDepartment of Ophthalmology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, SingaporeInstitute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A*STAR), Singapore, SingaporeSingapore Eye Research Institute (SERI), Singapore, SingaporeDepartment of Ophthalmology, National University Hospital, Singapore, SingaporeDepartment of Ophthalmology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, SingaporeInstitute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A*STAR), Singapore, SingaporeSingapore Eye Research Institute (SERI), Singapore, SingaporePolymeric biomaterials are biological or synthetic substances which can be engineered to interact with biological systems for the diagnosis or treatment of diseases. These biomaterials have immense potential for treating eyes diseases, particularly the retina—a site of many inherited and acquired diseases. Polymeric biomaterials can be engineered to function both as an endotamponade agent and to prevent intraocular scarring in retinal detachment repair surgeries. They can also be designed as a drug delivery platform for treatment of retinal diseases. Finally, they can be used as scaffolds for cellular products and provide non-viral gene delivery solutions to the retina. This perspective article explains the role of polymeric biomaterials in the treatment of retinal conditions by highlighting recent advances being translated to clinical practice. The article will also identify potential hurdles to clinical translation as future research directions in the field.https://www.frontiersin.org/articles/10.3389/fmed.2022.949543/fullretinal detachmentsdrug delivery systemmacular degenerationspolymerstem cellretinal disease
spellingShingle Ivan Seah
Ivan Seah
Ivan Seah
Charles Ong
Zengping Liu
Zengping Liu
Zengping Liu
Xinyi Su
Xinyi Su
Xinyi Su
Xinyi Su
Polymeric biomaterials in the treatment of posterior segment diseases
Frontiers in Medicine
retinal detachments
drug delivery system
macular degenerations
polymer
stem cell
retinal disease
title Polymeric biomaterials in the treatment of posterior segment diseases
title_full Polymeric biomaterials in the treatment of posterior segment diseases
title_fullStr Polymeric biomaterials in the treatment of posterior segment diseases
title_full_unstemmed Polymeric biomaterials in the treatment of posterior segment diseases
title_short Polymeric biomaterials in the treatment of posterior segment diseases
title_sort polymeric biomaterials in the treatment of posterior segment diseases
topic retinal detachments
drug delivery system
macular degenerations
polymer
stem cell
retinal disease
url https://www.frontiersin.org/articles/10.3389/fmed.2022.949543/full
work_keys_str_mv AT ivanseah polymericbiomaterialsinthetreatmentofposteriorsegmentdiseases
AT ivanseah polymericbiomaterialsinthetreatmentofposteriorsegmentdiseases
AT ivanseah polymericbiomaterialsinthetreatmentofposteriorsegmentdiseases
AT charlesong polymericbiomaterialsinthetreatmentofposteriorsegmentdiseases
AT zengpingliu polymericbiomaterialsinthetreatmentofposteriorsegmentdiseases
AT zengpingliu polymericbiomaterialsinthetreatmentofposteriorsegmentdiseases
AT zengpingliu polymericbiomaterialsinthetreatmentofposteriorsegmentdiseases
AT xinyisu polymericbiomaterialsinthetreatmentofposteriorsegmentdiseases
AT xinyisu polymericbiomaterialsinthetreatmentofposteriorsegmentdiseases
AT xinyisu polymericbiomaterialsinthetreatmentofposteriorsegmentdiseases
AT xinyisu polymericbiomaterialsinthetreatmentofposteriorsegmentdiseases